Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
erlotinib (tarceva) (1 trial)
Brain Neoplasms (Phase 2)
Neoplasm Metastasis (Phase 2)
Neoplasms, Second Primary (Phase 2)
Recurrence (Phase 2)
Trials (1 total)
Trial APIs (1 total)